Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
The predictive ability of the new European SCORE2 in primary prevention of an asymptomatic population
Session:
Comunicações Orais - Sessão 25 - Prevenção Cardiovascular e Reabilitação
Speaker:
Margarida Temtem
Congress:
CPC 2023
Topic:
J. Preventive Cardiology
Theme:
29. Rehabilitation and Sports Cardiology
Subtheme:
29.2 Cardiovascular Rehabilitation
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Margarida Temtem; Maria Isabel Mendonça; Marina Santos; Débora Sá; Francisco Sousa; Sofia Borges; Sónia Freitas; Eva Henriques; Mariana Rodrigues; António Drumond; Ana Célia Sousa; Roberto Palma Dos Reis
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong>Background:</strong> The European Society of Cardiology updated SCORE (Systematic Coronary Risk Evaluation) to the new SCORE2 algorithm, recommended for cardiovascular risk assessment in individuals without known cardiovascular disease (CVD) or diabetes to predict a ten-year risk of mortality or any CV events.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong>Objective:</strong> Evaluate the applicability of the new European SCORE2 in an asymptomatic moderate-risk region population for Major Adverse Cardiovascular Events (MACE) prediction. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong>Methods:</strong> Our study population comprises 1113 asymptomatic individuals without known CAD (mean age 53.3 years, 73.9 male) enrolled from the prospective arm of the GENEMACOR Study with a follow-up period over 5.9±4.3 years. The population was categorized according to SCORE2 into three risk groups (low-intermediate <5%; high 5-10%; very high >10%). We defined the primary endpoint of all-cause cardiovascular events (death and any CVD non-fatal event). Chi-square evaluates the traditional risk factor's percentage, Harrel C statistics <span style="background-color:white"><span style="font-family:"Calibri","sans-serif"">assess how good the risk model is in CV events discrimination,</span></span> and Kaplan-Meier estimates the survival.</span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong>Results:</strong> The study population presented dyslipidemia (68.8%), hypertension (51.0%), smoking (23.8%), family history (13.2%) and physical inactivity (43.0%). SCORE2 value at ten years of follow-up was 6.0±3.3. C-index with 95%CI showed good events discrimination ability (C index=0.725; 95% CI 0.645-0.805). At ten years of follow-up, Kaplan-Meier analysis estimated that event-free occurred in 99% of individuals in the low/moderate category, 89% in the high and only 73% in the very high-risk category. </span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong>Conclusion</strong>: SCORE2 algorithm showed a good quality discrimination model into risk categories (low/moderate, high and very-high-risk) and presented a good ability to predict future events in our population.</span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site